IGG4 RELATED DISEASE
Clinical trials for IGG4 RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IGG4 RELATED DISEASE trials appear
Sign up with your email to follow new studies for IGG4 RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop IgG4 disease relapses without Long-Term steroids
Disease control Not yet recruitingThis study tests a drug called IMM0306 in 125 people with IgG4-related disease, a condition where the immune system attacks organs causing swelling and damage. The goal is to see if IMM0306 can prevent disease flare-ups and allow patients to safely stop taking steroids. Participa…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE2, PHASE3 • Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Immune cells re-engineered to fight stubborn autoimmune disease
Disease control Not yet recruitingThis early-phase study tests a new treatment called CD19/BCMA CAR-NK cells for people with IgG4-related disease that has come back or not responded to standard care. The goal is to see if these specially engineered immune cells are safe and can put the disease into remission with…
Matched conditions: IGG4 RELATED DISEASE
Phase: EARLY_PHASE1 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC